Dutosme, Herminia S.

HRN: 01-03-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/01/2024
05/08/2024
IV
600mg
Q8
Infected Wound
Checking Final Appropriateness 
05/01/2024
CEFTRIAXONE 1G (VIAL)
05/01/2024
05/08/2024
IV
2g
OD
Infected Wound, Right Foot
Waiting Final Action 
05/01/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/01/2024
05/10/2024
IV
4.5g
Q8
DM Foot Right
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: